[go: up one dir, main page]

FI973469A0 - Förfarande för framställning av faktor IX ur biologiska källor - Google Patents

Förfarande för framställning av faktor IX ur biologiska källor

Info

Publication number
FI973469A0
FI973469A0 FI973469A FI973469A FI973469A0 FI 973469 A0 FI973469 A0 FI 973469A0 FI 973469 A FI973469 A FI 973469A FI 973469 A FI973469 A FI 973469A FI 973469 A0 FI973469 A0 FI 973469A0
Authority
FI
Finland
Prior art keywords
pct
biological sources
producing factor
sec
factor
Prior art date
Application number
FI973469A
Other languages
English (en)
Finnish (fi)
Other versions
FI119377B (sv
FI973469L (sv
Inventor
Djuro Josic
Lutz Hoffer
Frank Morfeld
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI973469A0 publication Critical patent/FI973469A0/sv
Publication of FI973469L publication Critical patent/FI973469L/sv
Application granted granted Critical
Publication of FI119377B publication Critical patent/FI119377B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI973469A 1995-02-25 1997-08-22 Förfarande för framställning av faktor IX ur biologiska källor FI119377B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19506633 1995-02-25
DE19506633A DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
PCT/EP1996/000636 WO1996027003A1 (en) 1995-02-25 1996-02-14 A process for the preparation of factor ix from biological sources
EP9600636 1996-02-14

Publications (3)

Publication Number Publication Date
FI973469A0 true FI973469A0 (sv) 1997-08-22
FI973469L FI973469L (sv) 1997-08-22
FI119377B FI119377B (sv) 2008-10-31

Family

ID=7755037

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973469A FI119377B (sv) 1995-02-25 1997-08-22 Förfarande för framställning av faktor IX ur biologiska källor

Country Status (20)

Country Link
US (1) US5919909A (sv)
EP (1) EP0811058B1 (sv)
JP (1) JPH11500910A (sv)
KR (1) KR100436857B1 (sv)
CN (1) CN1105779C (sv)
AT (1) ATE194167T1 (sv)
AU (1) AU697217B2 (sv)
CA (1) CA2213577C (sv)
DE (2) DE19506633A1 (sv)
DK (1) DK0811058T3 (sv)
EA (1) EA000222B1 (sv)
ES (1) ES2147365T3 (sv)
FI (1) FI119377B (sv)
GR (1) GR3034035T3 (sv)
IL (1) IL117157A (sv)
MY (1) MY119366A (sv)
PT (1) PT811058E (sv)
UA (1) UA46005C2 (sv)
WO (1) WO1996027003A1 (sv)
ZA (1) ZA961450B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
JP4855074B2 (ja) * 2003-09-30 2012-01-18 一般財団法人化学及血清療法研究所 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR100567448B1 (ko) * 2003-11-05 2006-04-04 주식회사 인투젠 형질전환 동물의 유즙 전처리방법 및 이를 통한 인체단백질의 정제방법
ATE489105T1 (de) 2004-03-19 2010-12-15 Baxter Int Faktor ixa zur behandlung von blutungsstörungen
US10434492B2 (en) * 2007-01-26 2019-10-08 Sigma-Aldrich Co. Llc Compositions and methods for solid phase extraction of lipids
US10928366B2 (en) * 2007-01-26 2021-02-23 Sigma-Aldrich Co. Llc Compositions and methods for combining protein precipitation and solid phase extraction
DK3133157T3 (da) * 2010-03-30 2019-08-12 Octapharma Ag Fremgangsmåde til oprensning af vitamin k-afhængige proteiner
CN104560925B (zh) * 2014-12-30 2017-11-03 山东泰邦生物制品有限公司 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
CN111378029B (zh) * 2018-12-29 2023-05-05 四川远大蜀阳药业有限责任公司 一种人凝血因子ix的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
JP3418621B2 (ja) 1991-03-01 2003-06-23 アヴェンティス ベーリング エルエルシー Ｉｘ因子の調製
CN1064552C (zh) 1993-02-09 2001-04-18 奥克塔法马有限公司 失活无脂质被膜病毒的方法
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Also Published As

Publication number Publication date
ES2147365T3 (es) 2000-09-01
CN1181782A (zh) 1998-05-13
CN1105779C (zh) 2003-04-16
US5919909A (en) 1999-07-06
JPH11500910A (ja) 1999-01-26
PT811058E (pt) 2000-10-31
AU4876196A (en) 1996-09-18
GR3034035T3 (en) 2000-11-30
IL117157A0 (en) 1996-06-18
DE69609054D1 (de) 2000-08-03
AU697217B2 (en) 1998-10-01
EP0811058A1 (en) 1997-12-10
EP0811058B1 (en) 2000-06-28
CA2213577A1 (en) 1996-09-06
DK0811058T3 (da) 2000-10-16
DE19506633A1 (de) 1996-08-29
UA46005C2 (uk) 2002-05-15
DE69609054T2 (de) 2001-03-08
CA2213577C (en) 2005-01-04
KR100436857B1 (ko) 2004-09-21
KR19980702453A (ko) 1998-07-15
WO1996027003A1 (en) 1996-09-06
IL117157A (en) 1999-12-22
FI119377B (sv) 2008-10-31
ATE194167T1 (de) 2000-07-15
ZA961450B (en) 1996-08-27
MY119366A (en) 2005-05-31
EA000222B1 (ru) 1998-12-24
EA199700196A1 (ru) 1998-02-26
FI973469L (sv) 1997-08-22

Similar Documents

Publication Publication Date Title
DE69424545D1 (de) Verfahren zur herstellung von immunoglobulin g konzentrat
DE60207848D1 (de) Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung
BR9909382A (pt) Anticorpo humanizado contra o fator tissular humano (tf) e processo de produção de anticorpo humanizado
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
DE69011859D1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
DE60027732D1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
DK0766745T3 (da) Monoklonalt antistof, som er specifikt for humant 4-1BB samt cellelinje, som producerer dette
ATE145007T1 (de) Verfahren zur herstellung monoklonaler antikörper mit hilfe eines keimfreien tieres
FI973469A0 (sv) Förfarande för framställning av faktor IX ur biologiska källor
ATE373014T1 (de) Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung,die dieses enthalten
SE9501808D0 (sv) New process
DE59606775D1 (de) Verfahren zur herstellung von natriumwolframat
ATE191457T1 (de) Verfahren zur herstellung von einem bicyclohexanderivat
DE50112449D1 (de) Verfahren zur herstellung von 3,3-diarylpropylaminen
DE59603295D1 (de) Verfahren zur herstellung von dolastatin 15 und deren zwischenprodukten
ATE43610T1 (de) Acino-foetale differenzierungsproteine verbunden mit krebs des pankreas, antiserum und monoklonale antikoerper gegen diese proteine und verfahren zu ihrer herstellung.
ATE309371T1 (de) Protein mit dnase-aktivität
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
DE59603908D1 (de) Verfahren zur Herstellung von N',N'-disubstituierten 1,4-Diaminoanthrachinonen
DE59611353D1 (de) Transketolase-verwandtes protein
DE3769442D1 (de) Neues verfahren zur herstellung von optisch aktiven carbacyclin-zwischenprodukten.
ATE123495T1 (de) Verfahren zur herstellung 2-chlor-1,7- dihydropurin-6-on und verfahren zu dessen reinigung.
DE50001638D1 (de) Verfahren zur herstellung von 4,6-dichlorpyrimidin
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
DE59407666D1 (de) VERFAHREN ZUR HERSTELLUNG VON 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDAN

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119377

Country of ref document: FI

MM Patent lapsed